calendar
33,898 catalysts · 14,063 approval · 5,000 device 510k · 4,728 grant · 3,316 8k filing · 2,000 device pma · 2,000 device recall
33,898 catalysts · 14,063 approval · 5,000 device 510k · 4,728 grant · 3,316 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION
Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION
Sponsor: BAUSCH. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL
Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: SUSPENSION. Route: ORAL
Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL
Sponsor: MYLAN TECHNOLOGIES. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: IMPAX LABS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS
Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL
Sponsor: LUPIN. Form: CAPSULE. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: EMULSION. Route: OPHTHALMIC
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ACTAVIS MID ATLANTIC. Form: SOLUTION. Route: ORAL
Sponsor: ENDO OPERATIONS. Form: IMPLANT. Route: SUBCUTANEOUS
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SANDOZ. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: PH HEALTH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: HARROW EYE. Form: SUSPENSION. Route: OPHTHALMIC
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: CHIESI. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: ABBVIE ENDOCRINE INC. Form: POWDER. Route: INTRAMUSCULAR
Sponsor: HQ SPECLT PHARMA. Form: INJECTABLE. Route: INJECTION
Sponsor: TEVA. Form: TABLET. Route: ORAL